Expression of , and in colon cancer and their influences on prognosis.

Background: This study aims to identify the core genes that influence the prognosis of colon cancer (CC) and analyze their relationships with clinical characteristics.

Methods: The gene expression profiles were downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed genes (DEGs) were identified. The top ten core genes were selected by bioinformatics tools and screened through the Oncomine database. The expression of core genes in CC tissues and cells was validated by immunohistochemistry, immunoblotting and quantitative real-time polymerase chain reaction. Spearman correlation was used to analyze the relationship between different parameters. Overall survival was assessed by the Kaplan-Meier method. The area under the curve (AUC) and the receiver operating curve (ROC) were applied to assess the accuracy of genes for predicting prognosis.

Results: There were 1,665 DEGs that were identified from TCGA database. Bioinformatics analysis found that , and were differentially expressed in CC tissue. Overexpression of , , , and in CC was associated with shortened survival time (P<0.05). In the validation studies, the high expression levels of , and in CC cells and tissues were confirmed compared to the control groups (P<0.05) and were adverse prognostic biomarkers (P<0.01). The combination prognostic model of the three core genes predicted the 1-, 3-, and 5-year survival of CC with AUCs of 0.868, 0.635 and 0.770, respectively.

Conclusions: High levels of , , and were associated with poor prognosis in CC. The combination prognostic model of these three genes could be a new option.